I haven't had a chance to read the annual report as yet. However with regards to consolidation it's a bit too early for me to yes or no.
I will need to see what results we have in the next 4c. If Carcdiocel revenue is increasing then I believe the consoldiation move is a correct one. Personally I don't believe mamangement would have gone down this path unless they were fairly certain that revenue will increase from here.
Obviously any positive news on the vaccine will make the consolidation decision moot as it will be the correct decision to do.
Haplo
I haven't had a chance to read the annual report as yet. However...
-
- There are more pages in this discussion • 141 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.98 |
Change
-0.020(0.20%) |
Mkt cap ! $208.6M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.80 | $89.97K | 9.122K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 344 | $9.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.99 | 180 | 1 |
View Market Depth
| Last trade - 14.50pm 11/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |